A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data

Показать другие версии (1)

Summary There is an urgent need for an improved TB vaccine. Vaccine development is hindered by the lack of immune correlates and uncertain predictive value of preclinical animal models. As data become available from human efficacy trials, there is an opportunity to evaluate the predictive value of t...

Полное описание

Библиографические подробности
Главные авторы:	McShane, H, Williams, A
Формат:	Journal article
Язык:	English
Опубликовано:	2014

Схожие документы

A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data.
по: McShane, H, и др.
Опубликовано: (2014)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
по: Minassian, A, и др.
Опубликовано: (2011)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
по: Angela M Minassian, и др.
Опубликовано: (2011-01-01)

Towards new TB vaccines
по: Brazier, B, и др.
Опубликовано: (2020)

A review of clinical models for the evaluation of human TB vaccines.
по: O'Shea, M, и др.
Опубликовано: (2016)

TB vaccines in clinical development
по: Ginsberg, AM, и др.
Опубликовано: (2016)

Progress and challenges in TB vaccine development
по: Voss, G, и др.
Опубликовано: (2018)

Experimental animal modelling for TB vaccine development
по: Pere-Joan Cardona, и др.
Опубликовано: (2017-03-01)

Need for more TB vaccine field sites.
по: Mcshane, H
Опубликовано: (2009)

TB vaccines in clinical development
по: Ginsberg, A, и др.
Опубликовано: (2016)

TB vaccines in clinical development
по: Ginsburg, A, и др.
Опубликовано: (2016)

Replacing, reducing and refining the use of animals in tuberculosis vaccine 1 research
по: Tanner, R, и др.
Опубликовано: (2016)

Tools for assessing the protective efficacy of TB vaccines in humans: in vitro mycobacterial growth inhibition predicts outcome of in vivo mycobacterial infection
по: Tanner, R, и др.
Опубликовано: (2020)

Progress and challenges in TB vaccine development [version 1; referees: 2 approved]
по: Gerald Voss, и др.
Опубликовано: (2018-02-01)

A mycobacterial growth inhibition assay (MGIA) for bovine TB vaccine development
по: Pepponi, I, и др.
Опубликовано: (2017)

Recent Developments in Preclinical DNA Vaccination
по: Kenji Okuda, и др.
Опубликовано: (2014-01-01)

TB vaccine development: where are we and why is it so difficult?
по: Wilkie, M, и др.
Опубликовано: (2014)

Using an effective TB vaccination regimen to identify immune responses associated with protection in the murine model
по: Pinpathomrat, N, и др.
Опубликовано: (2021)

Tools for Assessing the Protective Efficacy of TB Vaccines in Humans: in vitro Mycobacterial Growth Inhibition Predicts Outcome of in vivo Mycobacterial Infection
по: Rachel Tanner, и др.
Опубликовано: (2020-01-01)

DEVELOPING A NEW TB VACCINE: BOOSTING BCG WITH MVA85A
по: Mcshane, H
Опубликовано: (2008)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
по: Pathan, A, и др.
Опубликовано: (2012)

Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85A.
по: Whelan, K, и др.
Опубликовано: (2009)

Vaccines for tuberculosis
по: McShane, H
Опубликовано: (2013)

Quantitative SPECT imaging of 155Tb and 161Tb for preclinical theranostic radiopharmaceutical development
по: Helena Koniar, и др.
Опубликовано: (2024-09-01)

Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models
по: Kirill V. Kalnin, и др.
Опубликовано: (2021-04-01)

Designing an adaptive phase II/III trial to evaluate efficacy, safety and immune correlates of new TB vaccines in young adults and adolescents.
по: Rustomjee, R, и др.
Опубликовано: (2013)

Identification and evaluation of novel protective antigens for the development of a candidate TB subunit vaccine
по: Stylianou, E, и др.
Опубликовано: (2018)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
по: Tanner, R, и др.
Опубликовано: (2021)

Preclinical Animal Models for Q Fever Vaccine Development
по: Mahelat Tesfamariam, и др.
Опубликовано: (2022-02-01)

Vaccine strategies against tuberculosis
по: H McShane
Опубликовано: (2009-03-01)

New TB vaccine granted orphan drug status.
по: Lang, T, и др.
Опубликовано: (2005)

Insights and challenges in tuberculosis vaccine development
по: McShane, H
Опубликовано: (2019)

Preclinical efficacy investigation of human neutrophil elastase inhibitor sivelestat in animal model of psoriasis
по: A. S. Zhukov, и др.
Опубликовано: (2022-06-01)

A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
по: Rowland, R, и др.
Опубликовано: (2012)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
по: Tameris, M, и др.
Опубликовано: (2014)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
по: Harris, S, и др.
Опубликовано: (2013)

A non-human primate in vitro functional assay for the early evaluation of TB vaccine candidates
по: Rachel Tanner, и др.
Опубликовано: (2021-01-01)

Tuberculosis vaccines: beyond bacille Calmette–Guérin
по: McShane, H
Опубликовано: (2011)

Tuberculosis vaccines: Beyond bacilli Calmette-Guérin
по: McShane, H
Опубликовано: (2011)

Correction: Safety and Immunogenicity of Boosting BCG Vaccinated Subjects with BCG: Comparison with Boosting with a New TB Vaccine, MVA85A.
по: Kathryn T. Whelan, и др.
Опубликовано: (2011-01-01)